CEACAM5 and lung cancer: Third, we performed an open-label nonrandomized controlled trial in patients with gastrointestinal tumors who presented with lung metastases based on serum CEA levels as a control and compared the results in subsequent patients who underwent SGM-101–guided primary lung cancer resection.